Close
ACHEMA MIDDLE EAST 2026

Statins being overprescribed for growing number of kidney disease patients

A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol...

SAVOR-TIMI 53 sets new standard for cardiovascular outcome trials in diabetes

Uncertainty persists regarding whether drugs that lower sugar reduce the risk of heart attack, with some concerns that diabetes drugs may actually raise the...

FDA approves new drug to treat HIV infection

The U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an integrase strand transfer inhibitor...

Scientists discover potential new way to treat anxiety

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects, Vanderbilt University scientists will...

Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents

Small proteins called peptides that consist of 10 to 50 amino acids are being studied as cancer vaccines and as possibly safer, more effective...

Studies suggest new key to ‘switching off’ hypertension

A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the body to regulate blood...

New plan of attack in cancer fight

New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern medicine: a cure for...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...